SCHEMBL1999703

SCHEMBL1999703

NNc1ccc(Br)cc1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.42
MAPK1 P28482 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HSP90AA1 P07900 1/20 0.41
TLR9 Q9NR96 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
NPC1 O15118 2/20 0.38
HPGD P15428 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NFKB1 P19838 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
AGTR1 P30556 1/20 0.36
TSHR P16473 1/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL20984762 0.98 ALOX15 (0.41) ALOX15MAPK1ALDH1A1HSP90AA1TLR9
Hydrochloric Acid SCHEMBL31082749 0.98 ALOX15 (0.41) ALOX15MAPK1ALDH1A1HSP90AA1TLR9
Hydrochloric Acid SCHEMBL7823944 0.98 ALOX15 (0.41) ALOX15MAPK1ALDH1A1HSP90AA1TLR9
Sulfuric Acid SCHEMBL20984468 0.88 CA2 (0.41) ALOX15ALDH1A1HSP90AA1TLR9MEN1
Phosphoric Acid SCHEMBL20984888 0.88 NPC1 (0.41) ALOX15ALDH1A1HSP90AA1TLR9L3MBTL1
Oxalic Acid SCHEMBL20984934 0.88 ALDH1A1 (0.44) ALOX15ALDH1A1HSP90AA1TLR9MEN1
Nitric Acid SCHEMBL20984071 0.84 MEN1 (0.37) ALOX15MAPK1ALDH1A1HSP90AA1TLR9
SCHEMBL9983346 0.80 HSP90AA1 (0.41) ALOX15MAPK1ALDH1A1HSP90AA1TLR9
SCHEMBL11796056 0.79 ALOX15 (0.46) ALOX15MAPK1ALDH1A1HSP90AA1TLR9
SCHEMBL15423725 0.79 ALOX15 (0.46) ALOX15MAPK1ALDH1A1HSP90AA1TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105503939-B O-methoxy phenylhydrazone double-core titanium complex and its preparation method and application 山西大学 2017-12-05 CN claimed
CN-105503939-A O-methoxy phenylhydrazone dicaryon metal complex and preparation method and application thereof UNIV SHANXI 2016-04-20 CN claimed
CN-112409203-B Method for simultaneously synthesizing phenylhydrazine salt and pyruvic acid or glyoxylic acid 帕潘纳(北京)科技有限公司 2022-10-25 CN disclosed
CN-112409203-A Method for simultaneously synthesizing phenylhydrazine salt and pyruvic acid or glyoxylic acid 帕潘纳(北京)科技有限公司 2021-02-26 CN disclosed
CN-107663161-A A kind of continuous stream synthesis technique of phenylhydrazine salt and substituted benzene hydrazonium salt 上海惠和化德生物科技有限公司 2018-02-06 CN disclosed
CN-105503939-B O-methoxy phenylhydrazone double-core titanium complex and its preparation method and application 山西大学 2017-12-05 CN disclosed
CN-105503939-A O-methoxy phenylhydrazone dicaryon metal complex and preparation method and application thereof UNIV SHANXI 2016-04-20 CN disclosed
CN-103396428-B Zirconium metal complex of furan aldehyde (ketone) hydrazone as well as preparation method and application of zirconium metal complex UNIV SHANXI 2015-04-15 CN disclosed
CN-103396428-A Zirconium metal complex of furan aldehyde (ketone) hydrazone as well as preparation method and application of zirconium metal complex UNIV SHANXI 2013-11-20 CN disclosed
US-20110269763-A1 CRTH2 receptor ligands for medicinal uses 7TM PHARMA A/S (DK) 2011-11-03 US disclosed
US-8022063-B2 CRTH2 receptor ligands for medicinal uses 7TM PHARMA A/S (DK) 2011-09-20 US disclosed
CN-1980664-A CRTH2 receptor ligands for therapeutic use 7TM PHARMA AS (DK) 2007-06-13 CN disclosed
EP-1758579-A1 CRTH2 RECEPTOR LIGANDS FOR MEDICINAL USES 7TM Pharma A/S (DK) 2007-03-07 EP disclosed
WO-2005115382-A1 CRTH2 RECEPTOR LIGANDS FOR MEDICINAL USES 7TM PHARMA A/S (DK) 2005-12-08 WO disclosed
CN-1148340-A Treatment of 5HTZBMethods of receptor-related disorders LILLY CO ELI (US) 1997-04-23 CN disclosed
US-4017540-A INSECTICIDES, MITICIDES THE UPJOHN COMPANY (US) 1977-04-12 US disclosed
US-4014932-A ANTHELMINTICS, PESTICIDES, MITICIDES, INSECTICIDES THE UPJOHN COMPANY (US) 1977-03-29 US disclosed
US-3987234-A ACRYLIC ESTER POLYMERS HENKEL & CIE G.M.B.H. (DT) 1976-10-19 US disclosed
US-3932661-A Anthelmintic methods employing benzoyl chloride phenylhydrazones THE UPJOHN COMPANY (US) 1976-01-13 US disclosed
US-3931318-A ANTHELMINTICS, PESTICIDES THE UPJOHN COMPANY (US) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269763-A1 CRTH2 receptor ligands for medicinal uses HRH1, HRH2, HRH4 ALOX15 283/4885MAPK1 1317/4885ALDH1A1 505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.